Mesenchymal stromal/stem cell adipogenic differentiation
Materials Required
Principle
Mesenchymal stromal/stem cells are commonly verified by plastic adherence, MSC surface-marker profile, and in vitro differentiation into osteogenic, chondrogenic, and adipogenic lineages; adipogenic differentiation assays test the adipocyte-lineage potential of these cells by inducing lipid-droplet accumulation and adipocyte-marker expression[1][2]. The standard readout is intracellular neutral-lipid accumulation, most often visualized by Oil Red O staining; Oil Red O can be used qualitatively by microscopy and quantitatively by extracting retained dye and measuring absorbance at 510 nm[3][4].
MCE has not independently verified the accuracy of these methods. They are for reference only.
Experimental Materials
• Use phosphate-buffered saline for washing, formaldehyde or paraformaldehyde for fixation, isopropanol for Oil Red O preparation or dye extraction, and Oil Red O working solution for neutral-lipid staining[4][8].
• Oil Red O is the primary dye for lipid-droplet detection; adipogenic differentiation may also be evaluated by FABP4 immunostaining or by RT-qPCR markers such as PPARG, FABP4/aP2, LPL, and other adipocyte-lineage genes when those endpoints match the experimental question[5][8][9].
• Use a standard humidified cell-culture incubator, biosafety cabinet, tissue-culture plates, inverted microscope, bright-field or fluorescence microscope for stained lipid droplets, and a plate reader or spectrophotometer capable of measuring Oil Red O extract at 510 nm when quantitative dye extraction is performed[4][8].
Experimental Procedure
• Seed MSCs in tissue-culture plates and initiate adipogenic induction when cultures are near confluent or confluent, because published protocols for human MSCs and adipose-derived stromal cells commonly begin induction after expansion to a dense monolayer; reported cell-density experiments also found lipid vacuoles after 1-3 weeks across 5 × 103 to 3 × 104 cells/cm2, with more abundant lipid vacuoles at higher densities[5][6][10].
• Prepare adipogenic induction medium by supplementing basal medium with insulin, dexamethasone, IBMX, and indomethacin, or follow a peer-reviewed MSC/ASC protocol using the same induction class; the literature documents variability in exact concentrations, so this protocol should report the selected source-specific formulation rather than substituting unsupported concentrations[3][5][6][7].
• Remove growth medium from the MSC monolayer, wash gently with PBS if required by the selected source protocol, and replace with adipogenic induction medium[5][6][7].
• Culture induced cells under standard mammalian cell-culture conditions and renew induction medium according to the selected peer-reviewed protocol; published MSC and ASC adipogenic protocols commonly assess differentiation after approximately 2-3 weeks, and lipid vacuoles have been observed after 1-3 weeks in human bone-marrow MSCs cultured in adipogenic medium[5][6][10].
• Maintain non-induced MSCs in parallel as the negative control, and include a known adipogenic-responsive MSC/ASC batch or lineage-committed adipocyte precursor control when the study design requires a positive control; Zuk et al. used lineage-specific precursor cells as positive controls and control-medium cultures as negative controls in adipogenic assays[2].
• For Oil Red O staining, fix cells before staining, incubate with Oil Red O working solution, wash to remove unbound dye, and image lipid droplets by microscopy; published Oil Red O methods use fixation before staining and detect intracellular neutral lipids as the adipogenic readout[4][8].
• For quantitative Oil Red O analysis, extract retained Oil Red O dye and measure absorbance at 510 nm; this endpoint estimates intracellular lipid accumulation but should be interpreted together with microscopy and cell number or viability when experimental treatments may affect proliferation or survival[4][8].
• Successful adipogenic differentiation is indicated by intracellular lipid droplets in induced cells that are absent or lower in non-induced controls, increased Oil Red O signal, and adipocyte-marker expression such as PPARG and FABP4/aP2 when molecular endpoints are included[3][5][8][9].
• Analyze biological replicates independently and report the MSC source, donor or animal source, passage, seeding density, induction formulation, induction duration, staining method, imaging method, and normalization strategy, because the MSC adipogenic literature reports substantial protocol variability that affects comparability[3][6][8].
Troubleshooting
Problem: Weak or sparse Oil Red O staining.
• Possible Cause: Cell density or induction duration may be insufficient for robust lipid-droplet accumulation.• Literature-supported Solution: Use a dense MSC monolayer at induction and allow the reported 1-3 week adipogenic culture window, because lipid vacuoles were observed across 5 × 103 to 3 × 104 cells/cm2 after 1-3 weeks and were more abundant at higher density[10].
Problem: Oil Red O signal is difficult to compare between groups.
• Possible Cause: Qualitative microscopy alone may not capture differences in lipid accumulation.• Literature-supported Solution: Combine microscopy with extracted Oil Red O absorbance at 510 nm and report normalization, because Oil Red O extraction at 510 nm was developed for quantitative lipid-staining assessment and later protocols emphasize quantitative image or absorbance analysis[4][8].
Problem: Apparent reduced adipogenesis occurs after treatment exposure.
• Possible Cause: The treatment may reduce cell viability rather than specifically inhibit adipogenic differentiation.• Literature-supported Solution: Include viability or cell-number assessment alongside Oil Red O analysis, because triclosan studies in human MSC adipogenesis measured cytotoxicity together with morphology, lipid accumulation, and adipocyte biomarkers during a 21-day adipogenesis assay[11].
References:
- [1]. Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini FC, Krause DS, et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy. 2006;8(4):315-317. [Content Brief]
- [2]. Zuk PA, Zhu M, Mizuno H, Huang J, Futrell JW, Katz AJ, et al. Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng. 2001;7(2):211-228. [Content Brief]
- [3]. Scott MA, et al. Current methods of adipogenic differentiation of mesenchymal stem cells. Stem Cells Dev. 2011;20(10):1793-1804. [Content Brief]
- [4]. Ramírez-Zacarías JL, et al. Quantitation of adipose conversion and triglycerides by staining intracytoplasmic lipids with Oil red O. Histochemistry. 1992;97(6):493-497. [Content Brief]
- [5]. Fink T, et al. Adipogenic differentiation of human mesenchymal stem cells. Methods Mol Biol. 2011;698:243-251. [Content Brief]
- [6]. Ciuffreda MC, et al. Protocols for in vitro differentiation of human mesenchymal stem cells into osteogenic, chondrogenic and adipogenic lineages. Methods Mol Biol. 2016;1416:149-158. [Content Brief]
- [7]. Yu G, Floyd ZE, Wu X, Hebert T, Halvorsen YD, Buehrer BM, et al. Adipogenic differentiation of adipose-derived stem cells. Methods Mol Biol. 2011;702:193-200. [Content Brief]
- [8]. Kraus NA, et al. Quantitative assessment of adipocyte differentiation in cell culture. Adipocyte. 2016;5(4):351-358. [Content Brief]
- [9]. Gojanovich AD, Gimenez MC, Masone D, Rodriguez TM, Dewey RA, Delgui LR, et al. Human adipose-derived mesenchymal stem/stromal cells handling protocols. Lipid droplets and proteins double-staining. Front Cell Dev Biol. 2018;6:33. [Content Brief]
- [10]. Lu H, Guo L, Wozniak MJ, Kawazoe N, Tateishi T, Zhang X, et al. Effect of cell density on adipogenic differentiation of mesenchymal stem cells. Biochem Biophys Res Commun. 2009;381(3):322-327. [Content Brief]
- [11]. Guo LW, Wu Q, Green B, Nolen G, Shi L, LoSurdo J, et al. Cytotoxicity and inhibitory effects of low-concentration triclosan on adipogenic differentiation of human mesenchymal stem cells. Toxicol Appl Pharmacol. 2012;262(2):117-123. [Content Brief]